National Presto Industries, Inc.
National Presto Industries, Inc. (NPK), a company established in 1905 and headquartered in Eau Claire, Wisconsin, primarily serves the North American market through its diverse operations. The company is structured into three main divisions: Housewares/Small Appliances, Defense, and Safety. The Housewares/Small…
1D
+1.2%
1W
-1.7%
1M
-2.5%
6M
+3.7%
YTD
+39.6%
1Y
+35.8%
2Y
+96.9%
5Y
+79.6%
10Y
+73.5%
Next earnings date
23/10/2026 (in 6 days)
Volatility around earnings
~11% stronger price swings than usual
PRICE TARGET LOW
US$162.00
CONSENSUS
US$162.00
MEDIAN
US$162.00
PRICE TARGET HIGH
US$162.00
No current analyst ratings available.
P/E
24.88
P/B
2.6
EV/EBITDA
17.8
RETURN ON EQUITY
3.9%
NET MARGIN
10.8%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.7%
AS OF
05/07/2026
FREE FLOAT
67.5%
FLOAT SHARES
4,814,134
AVG. DAILY VOLUME (30D)
105,040
Morgan Jeffery Alan
National Presto Industries, Inc. is a company in the Industrials sector, Aerospace & Defense industry, headquartered in United States.
The CEO is Maryjo J. Cohen, the company employs around 1,200 people.
The IPO was on 17/03/1980; the stock trades on NYSE under the ticker NPK.
The average price target is US$162.00, ranging from US$162.00 to US$162.00, with a median of US$162.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 23/10/2026.
Around past earnings, price swings were roughly 11% stronger than usual.
Yes. The last dividend was US$1.00 per share, ex-date 09/03/2026, paid on 20/03/2026.
The dividend yield is 0.7% (as of 05/07/2026).
Comparable stocks include GE Aerospace, RTX, Boeing Company, Lockheed Martin, Howmet Aerospace, General Dynamics, Northrop Grumman and TransDigm Group.
Clicking "Analyze stock" lets five strategies assess National Presto Industries against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.